Cell Robotics Granted New Patent for Lasette Perforator for Diabetics.ALBUQUERQUE, N.M.--(BW HealthWire)--June 8, 1999-- Cell Robotics' receives patent for using a multi-mode laser beam for drawing blood with its Lasette products Cell Robotics International Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB: CRII CRII Cooperative Research in Information Infrastructure CRII Customer Returns Improvement Initiative ), developer of the Lasette, a laser finger perforator per·fo·rate v. per·fo·rat·ed, per·fo·rat·ing, per·fo·rates v.tr. 1. To pierce, punch, or bore a hole or holes in; penetrate. 2. used for sampling capillary blood, Tuesday announced the United States Patent and Trademark Office The United States Patent and Trademark Office (PTO or USPTO) is an agency in the United States Department of Commerce that provides patent protection to inventors and businesses for their inventions, and trademark registration for product and intellectual property has granted a patent for laser dermal dermal /der·mal/ (der´mal) pertaining to the dermis or to the skin. der·mal or der·mic adj. Of or relating to the skin or dermis. perforation per·fo·ra·tion n. 1. The act of perforating or the state of being perforated. 2. An abnormal opening in a hollow organ or viscus, as one made by rupture or injury. Perforation A hole. to a team of scientists led by Cell Robotics' David Costello. This is an important patent regarding the characteristics of laser beams used for sampling blood. The new patent covers various means for producing and using multi-mode laser beams for effective and painless blood sampling. The scientific team has assigned all patent rights to Cell Robotics International Inc. Ronald K. Lohrding, Ph.D., chairman, president and chief executive officer of Cell Robotics, commented, "We are pleased to have the laser dermal perforator patent. We believe this provides us a level of patent protection that will make it more difficult for potential competitors to enter the market. "This patent also represents the innovation, ingenuity and dedication of David Costello, the other inventors and Cell Robotics' scientific team. We look forward to the Lasette market opportunity that lies ahead." The Professional Lasette is currently available to medical professionals for drawing capillary blood for all screening purposes and may be purchased by individuals with a doctor's prescription. The greatest demand for capillary blood samples is in the treatment of the world's 100 million diabetic patients who are often required to sample blood several times each day. Later this summer, Cell Robotics plans to introduce a smaller Personal Lasette for use by diabetes patients at home. Chronimed Inc., (Nasdaq: CHMD CHMD Change Mode Command ) of Minneapolis is the exclusive distributor and marketer of both Lasette models. The Professional and Personal Lasettes utilize a multi-mode Erbium:YAG laser to produce tiny holes in patient's fingertips through which blood samples may be obtained. The Lasette has recently been honored by the publication, Phontonics Spectra of the laser industry as one of the 25 most important new products of the last year. In addition to Cell Robotics' Costello, other inventors include Russian scientists Dr. Valeri Polushkin, Sergei Kokhanovsky and Alex Dergatchev, as well as Warren Parkhurst, an American living in Russia. Polushkin, is the director of the New Technology Engineering Center in Troitsk, Russia and continues to work with Cell Robotics on the Lasette product line. In addition to the Lasette, Cell Robotics International Inc. manufactures, markets, and distributes an In Vitro Fertilization in vitro fertilization (vē`trō, vĭ`trō), technique for conception of a human embryo outside the mother's body. Several ova, or eggs, are removed from the mother's body and placed in special laboratory culture dishes (Petri dishes); (IVF IVF in vitro fertilization. IVF abbr. in vitro fertilization IVF 1 In vitro fertilization, see there 2. Intravascular fluid ) Workstation that is increasing fertility rates in Europe, and the Cell Robotics Workstation, a research instrument that incorporates the LaserTweezers(R) and LaserScissors(TM) for manipulating and cutting cells and chromosomes. Additional information is available on the Cell Robotics Web Site at http://www.cellrobotics.com, by e-mail at crii@cellrobotics.com, or by telephone at 505/343-1131. As a cautionary note to investors, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; the company's ability to execute its service and product sales plans; and the risks described from time to time in the company's Securities and Exchange Commission filings. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion